GOOD MEDICINE CHOICE, INC., a collaborative network of research scientists and practitioners, has launched a new health blog, Podcast and product line in their efforts to fight the Coronavirus pandemic. The website, GoodMedicineChoiceNetwork.com, offers guidance on maintaining a healthy immune system and supplemental products to protect against chronic and infectious diseases with current focus on COVID-19.

The site will donate 10% of profits from product sales to support charities, including Advocates for Disabled Americans, Veterans, Police, Fireman & Families (ADA VETs).

GOOD MEDICINE CHOICE, INC. has researched and developed a variety of health products including anti-inflammatory and antioxidant supplements, multivitamins and essential oils under the trademark “Good Medicine Choice.” Visit our Store to learn more. The site also hosts a new podcast, Coronavirus Education, which is available for download on Apple iTunes, Stitcher and TuneIN.

Our website is provided as a resource by a network of doctors and specialists with expertise in telemedicine, chronic disease, immune system health, brain health, integrative medicine, health informatics and pharmaceutical and medical device research and development. Main partners of GOOD MEDICINE CHOICE, INC. include MJA Research and Development, Inc., which leads the company in intellectual property and product development, as well as GoMD Virtual Healthcare Network, championing the company’s telemedicine efforts.

GOOD MEDICINE CHOICE, INC. has spent the last three months at the forefront of efforts to fight the coronavirus pandemic. Formed in 2016, the group is a leader in research into Cytokine Storms resulting from COVID-19 disease, as well as research and development into solutions for immuno-defense, and providing personal protective equipment (PPE) for healthcare organizations. In addition to their nutritional supplement line, GMC has established a virtual healthcare network to provide medical assessments during the shutdown.

Principals Leading Six-Month Controlled Study on COVID-19 Risk Factors
The principals of the Network include Dr. Mikhail Artamonov, MD; Thomas J. Lewis, PhD; and Michael Carter, MD. (Bios below.) The group is leading a six-month open-label, randomized, controlled study demonstrating how use of hyperinflammatory markers and other measures of immune health are useful in risk stratifying patients for general health, chronic disease risk, and risk for severe COVID-19 outcomes.

Good Medicine Choice likewise focuses on how to avoid exposure to SARS-CoV-2 and other infectious disease, risks associated with severe symptoms or even dying from COVID-19, and how individuals can measure and reverse their risks of chronic conditions and infection. The website provides tips on social distancing, testing, vaccine and treatment clinical research, In addition, resources regarding Coronavirus financial help and coping during the pandemic shutdown are made available.

I’m particularly proud of the fact that 10% of the company’s profits are contributed to charities including ADA VETs, an organization working closely with families of disabled veterans to meet their needs

– Dr. Artamonov, CEO of the GMC.

Podcast Features Latest Research on SARS-CoV-2 and COVID-19
Featuring research and information from Dr. Lewis and his colleague Dr. Carter, the Coronavirus Education Podcast covers topics that explore what it means to be immunocompromised, how to strengthen immunity from Coronavirus and other viruses, and symptoms and potential treatments to treat COVID-19.

We aim to provide information on how to protect yourself and your family not just during the current pandemic crisis but also in the future, as our highly connected world presents the risk of future threats to your health. The data is in: The virus is highly contagious, forcing governments to curb group activities, the impact of which is severe economic and social disturbances that may last months more.

added Dr. Lewis.

About the Good Medicine Choice Network Experts

Dr. Mikhail Artamonov, CEO, is a medical practitioner and cofounder of GoMD, a virtual healthcare provider that has worked with several partners to develop and create technologies for the healthcare industry throughout the world. Dr. Artamonov earned his medical degree at the prestigious 1st Moscow Medical Sechenov School, and over the course of his career trained in several specialties including Neurology and Physiatry, Anesthesiology, Psychiatry, and Internal and Integrative Medicine. Dr. Artamonov trained in major institutions around the world including Harvard Cornell Universities. He is Board Certified in eight major areas of Medicine: Physical Medicine and Rehabilitation; Pain Medicine; Addiction Medicine; Brain Medicine; Functional, Regenerative and Anti-Aging Medicine; and Independent Medical Examination; and holds a number of smaller board certifications.

Thomas J. Lewis, Ph.D. studied at MIT and continued his education at Harvard School of Public Health. Since his father died 20 years ago of Alzheimer’s disease, he has dedicated his life to determining how to better predict Alzheimer’s and chronic diseases in general with a mission to replace the current “sick care” standard-of-care approach with a true “health care” approach. He is an entrepreneur and healthcare professional with expertise in toxic substances, drug development, biotechnology, health technology, and medical protocol development. Working with key clinicians at Harvard Medical School, his team developed an advanced diagnostic protocol, “4-Dimensions of Health,” utilizing AI-driven algorithms to measure risks and other determinants of chronic disease root cause prevention, screening, diagnosis and treatment. Dr. Lewis has written two books: “The End of Alzheimer’s – A Differential Diagnosis Toward a Cure,” and “Quarterback Your Own Health – How to Take and Lower Your Chronic Disease Temperature.”

Dr. Michael Carter is a board-certified physician and CMO of Functional Medicine at GoMD and Health Revival Partners, and Corporate Medical Director of Real Health Clinics. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine. He has obtained educational certifications in topics including stem cells, energy medicine, nutrition and advanced peptides. By addressing hormonal, adrenal, immune, GI and endocrine systems that are critical for balancing, Dr. Carter has created a proven path for successful and optimal health. He is co-inventor of the 4-Dimensions of Health program that identifies risk and causes of disease at the root level and maps a personalized care plan to help reverse factors contributing to an individual’s disease. Dr. Carter is a member of the American Academy of Anti-Aging Medicine and the Institute for Functional Medicine and he completed the stem cell fellowship and peptide certification programs at the A4M. He completed his medical degree at Howard University and College of Medicine and his residency at Emory University School of Medicine.